We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Supreme Court Passes On Schering-Plough Appeal

Law360 (June 26, 2006, 12:00 AM EDT) -- In a move that could open the floodgates for controversial patent settlement deals between brand-name and generic drug companies, the nation’s highest court Monday turned down the U.S. Federal Trade Commission’s appeal in the closely watched Schering-Plough case.

The U.S. Supreme Court’s rejection came after months of debate between the FTC and the U.S. Solicitor General's office as to whether the justices should hear the case amid the FTC’s wider probe into anti-competitive practices in the prescription drug industry.

Christopher M. Curran, partner at White &...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.